MVM News Archive

Rotavirus infection extends beyond gut to blood (April 17, 2007)
Dr. Janet Butel receives award for women in cancer research (April 9, 2007)
New interinstitutional grant to train next generation of biomedical scientists headed by Dr. Timothy Palzkill (October 5, 2006)
Dr. Mary K. Estes was awarded the Cullen Foundation Endowed Chair.(August 9, 2006)
Calicivirus research highlighted in Nature Microbiology Reviews (July 2006)
Knowledge of protein structure may shed light on avian flu virus (May 22, 2006)
Understanding DNA tangle could open door to new treatments for cancer, infectious diseases (March 14, 2006)
Computational advancements open door to virus, cell interactions (February 2, 2006)
Drug resistance may travel same path as quorum sensing (February 6, 2006)
Dr. Cliona M. Rooney, Professor of Molecular Virology and Pediatrics announced co-winner 2005 Michael E. DeBakey M.D. Faculty Excellence in Research awards.(November 22, 2005)
Dr. Mary K. Estes named to Institute of Medicine (October 24, 2005)
Stressed cells spark DNA repair missteps, speed evolution (October 17, 2005)
UTMB, BCM contracted to test avian flu drugs (November 4, 2005)
Dr. Mary Estes and colleagues have established a mammalian cell-based system for analysis of human norovirus replication. This will make it feasible to investigate antiviral agents in mammalian cells. Norovirus is responsible for most outbreaks of nonbacterial gastroenteritis in the United States and Europe and is classified as a Category B biodefense pathogen
Study focuses on dosage of Norwalk virus needed to cause illness (October 11, 2005)
A study by Dr. Tony Piedra and Dr. Paul Glezen and their colleagues found that "herd" vaccination of approximately 20 - 25 % of school-aged children with an attenuated influenza vaccine resulted in an indirect protection of 8 - 18% of adults from influenza. This may be a useful strategy for protecting the susceptible elderly population from influenza and in maximizing community protection from influenza with limiting doses of vaccine.(February, 2005)
Glezen named outstanding infectious disease Physician of the Year (May 18, 2004)